Latest news
Corvus Pharmaceuticals (NASDAQ:CRVS) Posts Earnings Results, Misses Expectations By $0.03 EPS - MarketBeatMarketBeat · Sat, 08 Aug 2026 04:52:38 GMTState Street Corporation (NYSE: STT) discloses 5.3% ownership in Corvus Pharmaceuticals - stocktitan.netstocktitan.net · Fri, 07 Aug 2026 13:17:03 GMTCorvus Pharmaceuticals Inc (CRVS) (Q2 2026) Earnings Call Highlights: Advancing Soquelitinib ... - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 05:09:15 GMTCorvus Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 03:43:00 GMTCorvus Pharmaceuticals Q2 Earnings Call Highlights - MarketBeatMarketBeat · Fri, 07 Aug 2026 00:10:04 GMTCorvus Eczema Trial Is Expected to Enroll About 200 Patients - stocktitan.netstocktitan.net · Thu, 06 Aug 2026 23:04:17 GMTCorvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:01:00 GMTHow to beat Corvus in Beast of Reincarnation - Eurogamer.netEurogamer.net · Thu, 06 Aug 2026 16:06:43 GMT